February 1, 2017
Donate
Print This Page

Did you know?

  • We envision a world free from cancer.

    Our research scientists and their teams collaborate with colleagues around the world to conduct cutting-edge research using large data-sets to:
    • understand the causes of cancer
    • find ways to prevent it or detect it early
    • improve outcomes for cancer survivors 
  • Our mission began more than 40 years ago.

    Established in 1974 as the Northern California Cancer Program, the organization later became known as the Northern California Cancer Center. The name was changed again in 2010 when it became the Cancer Prevention Institute of California (CPIC), which reflects the organization's broader scope and demonstrates its large scale impact of preventing cancer before it starts.
  • We are an independent research institute and a valued partner to many.

    Through its collaborative approach, CPIC also serves as an asset to the nation’s leading cancer fighting organizations, including the National Cancer Institute, and to scientists worldwide, educators, patients, and clinicians, and is affiliated with the Stanford Cancer Institute.
  • We work hard to understand who gets cancer and why.

    Our scientists are frequent contributors to major scientific journals, and often present their findings at important cancer-related conferences. CPIC research has been covered by numerous local, national and international media outlets, such as The New York Times and The Washington Post.
  • Every case of cancer counts…and is counted.

    CPIC operates the Greater Bay Area Cancer Registry as part of the National Cancer Institute's Surveillance, Epidemiology and End Results program and the California Cancer Registry. As required by law, the registry gathers data from hospitals and doctors on all cancers diagnosed and treated in nine Bay Area counties. This information is used to produce cancer statistics and as a platform for research to understand cancer occurrences and survival. Our registry regularly earns Gold Standard Certification by the North American Association of Central Cancer Registries.
  • Our educational efforts reach people of all ethnicities and backgrounds.

    Our Community Education team provides important information to cancer survivors, health professionals and others through conferences and publications on many cancer-related topics including employment, patient advocacy, care giving, specific cancers, and treatments.

  • Breast cancer rates decline when hormone therapy is stopped.

    CPIC was first to report on the alarmingly high and increasing rates of breast cancer in the Bay Area and Marin County in the 1990s. In subsequent studies, CPIC found that when women stopped taking hormone replacement therapy, breast cancer rates declined immediately and dramatically. This showed that hormone therapy was a major contributor to the high rates previously reported and identified one clear path to breast cancer prevention.
  • Our work to associate tanning beds and melanoma prompted legislation.

    CPIC described increased occurrence of melanoma in young women in California, particularly in high socioeconomic areas, implicating use of tanning beds as one cause. This finding led to passage of the first statewide legislation to ban minors from using tanning beds, which should ultimately reduce occurrences of deadly melanoma in young persons.
  • Physical activity lowers your risk of Breast Cancer

    CPIC found that risk of breast cancer was lower for women engaging in more physical activity, such as walking and biking, doing household chores and yard work, and being active on the job. This shows a simple and practical way women can help prevent breast cancer from occurring.
  • Second-hand smoke increases the risk of lung and breast cancer.

    CPIC studies have shown that women exposed to second-hand tobacco smoke have a higher risk of lung cancer even if they don't smoke, and that exposure to household smoke increases their risk of breast cancer over and above the risk they incur from smoking themselves. These findings have been important in leading to anti-smoking legislation.
  • Vitamin D may reduce the risk of prostate cancer.

    CPIC assessed whether sun exposure, which is the main source of vitamin D, is related to prostate cancer risk. Using the difference in skin color measured on the forehead and upper underarm as an indicator of sun exposure, the study found that prostate cancer risk was reduced by 50% in men with a high sun exposure index, with an even higher reduction in risk noted in men with certain alterations in the vitamin D receptor gene.
  • Survival outcomes differ among Asian women of different ethnic backgrounds.

    CPIC was the first to show that breast cancer survival is not uniform across women of different Asian ethnicities, irrespective of how advanced the cancer was when diagnosed. In California, Korean, South Asian and Vietnamese women had the poorest survival after breast cancer, pointing to the need in these communities for better screening and/or breast cancer treatment.
  • Melanoma is on the rise throughout California.

    CPIC demonstrated that the rates of both early and more advanced melanomas were rising in all populations in California. This disturbing finding signals a true and alarming epidemic of this deadly cancer, and it has been cited over 245 times in the medical literature since 2009 because it identifies a major public health problem.
  • Survival disparities occur across many cancer types.

    CPIC showed that survival after follicular lymphoma, a common form of this cancer, is lower in poorer communities than in more affluent communities. This demonstrates population disparities in cancer treatment and shows a need in poorer communities for more access to skilled lymphoma care, including access to new successful drug treatments.
  • Our nail salon studies have widespread positive impact.

    CPIC found that California nail salons had higher than expected levels of carcinogens and other banned substances in the air, identifying the need for better standards and the importance of clarifying whether such exposures lead to cancer and other undesirable health outcomes.
  • Tailored approaches to healthcare are needed to address cultural differences.

    CPIC used two approaches to learn how best to help Vietnamese communities in California receive lifesaving colorectal cancer screening: one approach involved lay health workers directly educating the community on the importance of screening, and the other involved advertising about colorectal cancer screening. CPIC found that the use of lay health workers worked best to improve the screening rate, proving that organized community involvement improves colorectal screening practices among Vietnamese-Americans in California.
  • Lung cancer afflicts nonsmoking women more than men.

    CPIC was the first to show definitively that among nonsmokers, women were more likely than men to have lung cancer. Until this paper, there were no hard data about the incidence of lung cancer in nonsmokers. This study has been cited extensively as motivation for other research to understand the reasons why.
  • Genetic screening is especially important for African American and Hispanic women.

    CPIC was the first to study the level of BRCA1 mutations (genetic changes responsible for increased risk of breast cancer) in nonwhite women. This work found that young African American and Hispanic women with breast cancer had a particularly high prevalence of BRCA1 mutations, and signaled the importance to these communities and their doctors of screening for this mutation when indicated.

Press Releases

Empowering and Connecting Survivors For 16 Years — Bay Area Annual Breast Cancer Conference To Be Held in San Francisco March 4

Conference to address latest treatments, genetics, nutrition, financial considerations and more

FREMONT, CALIF. (January 31, 2017) – How do you ride the emotional roller coaster of breast cancer?

What are the latest techniques to reduce recovery time and increase mobility after cancer surgery?

How do patients and their families sustain working relationships with a breast cancer medical team? 

What is the role of nutrition and exercise in reducing cancer risk? 

What is the latest research on genetics and the value of testing individuals who have a risk of an inherited cancer disposition? 

Answers to these and other questions, combined with personal stories of those coping with cancer, will be addressed at Current Breast Cancer Landscape in the Bay Area, the 16th annual breast cancer conference of the Cancer Prevention Institute of California (CPIC).  The event is scheduled for 8:00 a.m. to 3:30 p.m., Saturday, March 4, at the Golden Gate Club, 135 Fisher Loop, in the Presidio San Francisco. 

Featuring nationally and regionally prominent medical experts, the conference is expected to be filled to capacity at 225 people. The conference offers an abundant source of answers, dialogue, the latest research and compassion. Cancer patients and survivors benefit by receiving the trustworthy information they need to make informed decisions about their health. Participants will emerge from the conference with new ideas about treatment, nutrition, genetics, estate planning, fertility and family planning.

Among the participants who has benefitted from the conferences is Ariana N. She’s attended every conference since 2014 – the same year she was diagnosed with Stage 1, Grade 3 breast cancer at the age of 44. She said, “The conference addresses the constellation of concerns that accompany a cancer diagnosis. I enjoy attending the conference each year because the information is delivered in a way that can be understood by both medical practitioners and survivors.”

“This is a one-of-a-kind conference that goes beyond the latest treatments to provide information and emotional support to empower people and their families dealing with breast cancer,” said Donna Randall, chief executive officer of the Cancer Prevention Institute of California.  “Since its inception, the conference has benefitted more than 3,000 patients and their family members. Last year, 89 percent of participants rated the conference as excellent. It’s about dialogue and ideas and laying the foundation of informed decision-making. The conference gives participants practical tools to help anyone touched by breast cancer.”

One much-anticipated conference speaker is Dr. Allison W. Kurian. Kurian, director of the Women’s Clinical Cancer Genetics Program at the Stanford University School of Medicine will discuss new techniques to identify women with an elevated risk of breast and gynecologic cancers during her keynote address.

Dr. Mark C. Rounsaville, a radiation oncologist at California Pacific Medical Center specializing in breast cancer and assistant clinical professor of radiation oncology at the University of California San Francisco, School of Medicine, will once again moderate the morning presentations. He is the author and/or coauthor of numerous scientific journal articles.

There will be a new breakout session titled, “Networking to address breast cancer disparities: Learning from researchers, community partners and advocates, and survivors,” featuring a panel of experts from CPIC, Zero Breast Cancer, the Tirbucio-Vasquez Health Center, UCSF and Stanford. The aim of the session is to identify critical research questions important to underserved populations, and to promote collaborative work across different segments of the breast cancer community. The audience will be encouraged to participate in the dialogue during the session.  

Yoly Bott, an advocate for early detection and self-exams from the Bay Area Young Survivors (BAYS), will share her personal story. She chairs the events committee for the board of BAYS, which provides support to women diagnosed with breast cancer before the age of 45.

Iona Cheng, a research scientist with CPIC and the Stanford Cancer Institute, will share recent trends in breast cancer incidence in the Bay Area. Dr. Cheng’s research, recognized in many media outlets, looks at ethnic differences in cancer, genetic epidemiology, neighborhood environment and cancer risk, and causes of colorectal, lung, prostate and breast cancers. 

Other speakers include:
• Dr. Mitchell Rosen, a reproductive endocrinologist and fertility expert at the University of California San Francisco Center for Reproductive Health and director of the UCSF Fertility Preservation Center 
• Barbara Cicerelli, director of breast & cervical cancer services for the San Francisco Department of Public Health
• Elizabeth Castillo, bilingual cancer navigation specialist for the San Francisco Department of Public Health
• Kerry Kingham, a licensed genetic counselor at the Stanford Cancer Institute 
• Timaree Hagenburger, an author and nutrition professor at Cosumnes River College 
• Rabbi Lori Klein, the director of Spiritual Care Service at Stanford Health Care, a teacher on topics such as palliative care and spiritual assessment for patients 
• Robert L. Harrison, an attorney specializing in estate planning techniques, such as wills, trusts, power of attorney and Advance Health Care Directives.
• Dr. Judy Luce, a nationally-recognized breast cancer expert, will explain breast cancer screening and treatment updates and discuss treatment options for Ductal Carcinoma in Situ (DCIS), an early non-invasive form of the disease.  She is a clinical professor emeritus at the University of California at San Francisco (UCSF) where she served as chairwoman of the Protocol Review Committee at its Comprehensive Cancer Center.  She is also former director of oncology services at San Francisco General Hospital. A CPIC trustee, Dr. Luce has had a career-long interest in community-based education and cancer control including a focus on screening and follow up care for low-income and ethnic minority women.

Breakfast and lunch are included in the registration fee of $30. A scholarship program is available for those who cannot afford the fee. The California Breast Cancer Research Program is the exclusive Survivor Champion sponsor of this year’s conference. Stanford Cancer Institute is a Research sponsor.


Visit the CPIC website for more about the conference, or call 510 608-5094 or email education@cpic.org.  

About the Cancer Prevention Institute of California
The Cancer Prevention Institute of California is a nonprofit organization dedicated to preventing cancer and to reducing its burden where it cannot yet be prevented. We are the only freestanding research institution working solely to prevent cancer using extensive population data. CPIC researchers study a wide range of cancer risk factors, such as racial/ethnic background, socioeconomic status, age, occupation, gender, genetic predisposition, geographic location, environment and lifestyle to determine how these factors affect frequency, distribution and types of cancers. For more information, visit the CPIC website at www.cpic.org

Media contact: 
Jim Zelinski, Zelinski Public Relations: 925-242-0918 or 415-420-6050|jimz@zelinskipublicrelations.com

# # #